
Is Zimmer Biomet (ZBH) stock Halal?
Verdict for Zimmer Biomet (ZBH): not Shariah compliant (FAIL). Screened October 2026 under AAOIFI Shariah Standard No. 21. Business activity: pass. Non-permissible income: pass. Interest-bearing investments: pass. Interest-bearing debt: fail. Preference shares: pass. Dividend purification factor: not applicable. Next review: November 2026.
Zimmer Biomet is a leading global medical technology company specializing in the design, manufacture, and marketing of orthopedic reconstructive products. Its portfolio encompasses knee and hip implants, sports medicine solutions, biologics, trauma devices, and extremities products, as well as craniomaxillofacial and thoracic offerings for facial and chest reconstruction. Zimmer Biomet also integrates advanced digital and robotic technologies, artificial intelligence tools, and surgical instruments to enhance mobility and support joint and bone health. For Muslim investors, though, the most pressing question is simpler: is Zimmer Biomet a Halal investment?
Is Zimmer Biomet Shariah compliant?
No. In the October 2026 screening Zimmer Biomet (ZBH) does not pass AAOIFI screening: it fails the interest-bearing debt screen. Medicines and medical devices are permissible, and healthcare companies like Zimmer Biomet usually clear the activity screen comfortably. What AAOIFI Shariah Standard No. 21 watches is the financing behind the pipeline: drug development is expensive, and the 30% interest bearing debt cap decides the verdict more often than the science does.
Does Zimmer Biomet pass the business activity test?
The activity screen is only part of the picture this month: Zimmer Biomet currently fails the interest-bearing debt screen, so the overall verdict is not compliant regardless of the business itself. Treating illness is permissible work; the scrutiny belongs to the financing behind it.
Is Zimmer Biomet's income Halal?
Yes, within AAOIFI's tolerance. Zimmer Biomet's income from non-permissible sources stays below 5% of revenue in the October 2026 screening.
Does Zimmer Biomet meet AAOIFI's debt and investment ratio requirements?
Not in full. Interest bearing debt currently exceeds the 30% cap, measured against a market capitalisation of $16.9B (market data as of 1 October 2026), while the other ratio stays within it. One breach is enough to fail the screening; the ratios are reassessed monthly under our Shariah Supervisory Board.
Why do other halal screeners show a different verdict for Zimmer Biomet?
Screeners can disagree without either being wrong. AAOIFI Shariah Standard No. 21, which Tabadulat applies, measures interest bearing debt and investments against market capitalisation with a 30% ceiling. MSCI and FTSE measure them against total assets with a 33% ceiling, and S&P and Dow Jones Islamic use a multi year average of market capitalisation. Data dates differ too, because each provider reads filings and prices on its own schedule. The same company can therefore pass one standard and fail another in the same month. Tabadulat publishes one answer, the AAOIFI result as of October 2026, and re-screens it every month.
Tabadulat is an ADGM regulated brokerage whose license covers Shari'a Compliant Regulated Activities, as the FSRA permission names them. New to the terminology? Gharar and Maysir, Sukuk, Zakat and purification are all explained in plain English.
New to the screening method? Read What is Halal Investing? A Guide to Halal Stocks and Islamic Finance










